Cardiff Oncology Inc
SWB:XE7C
Cardiff Oncology Inc
SWB:XE7C
Price:
1.363
EUR
-4.69%
Market Closed
Market Cap:
€61m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cardiff Oncology Inc
SWB:XE7C
|
US |
|
Marubeni Corp
F:MAR0
|
JP |
|
C
|
Continental AG
F:CON
|
DE |
|
S
|
Sino Land Co Ltd
OTC:SNLAY
|
HK |
|
D
|
Diageo PLC
XBER:GUI
|
UK |
|
I
|
Insperity Inc
XBER:ASF
|
US |
|
ING Groep NV
XETRA:INN1
|
NL |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
BM |
|
T
|
Terna Rete Elettrica Nazionale SpA
F:UEI
|
IT |
|
Secom Co Ltd
TSE:9735
|
JP |
|
D
|
DR Horton Inc
SWB:HO2
|
US |
|
I
|
Itochu Corp
OTC:ITOCY
|
JP |
|
Element Fleet Management Corp
F:61F
|
CA |
|
K
|
KGHM Polska Miedz SA
XBER:KGHA
|
PL |
|
Sumber Alfaria Trijaya Tbk PT
OTC:PSBAF
|
ID |
|
Escorts Kubota Ltd
NSE:ESCORTS
|
IN |
|
L
|
Lithia Motors Inc
XBER:LMO
|
US |
|
Great Elm Capital Corp
NASDAQ:GECC
|
US |
Wall St Price Targets
XE7C Price Targets Summary
Cardiff Oncology Inc
Cardiff Oncology Inc
Wall Street analysts forecast XE7C stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for XE7C is 7.5 EUR with a low forecast of 3.033 EUR and a high forecast of 10.809 EUR.
Lowest Forecast
Price Target
3.033
EUR
122% Upside
Average Forecast
Price Target
7.5
EUR
450% Upside
Highest Forecast
Price Target
10.809
EUR
693% Upside
Cardiff Oncology Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XE7C's stock price target?
Price Target
7.5
EUR
7.5
EUR
According to Wall Street analysts, the average 1-year price target for XE7C is 7.5 EUR with a low forecast of 3.033 EUR and a high forecast of 10.809 EUR.
What is the Revenue forecast for Cardiff Oncology Inc?
Projected CAGR
166%
166%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 166%.
